ArticleClinical drug investigation2020

Nivolumab Versus Docetaxel for Previously Treated Advanced Non-Small Cell Lung Cancer in China: A Cost-Effectiveness Analysis.

Qiao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.